Aparna Ambay, MD
Dermatology · Wesley Chapel, FLNPI 1467417899
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 282 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 12.6% — the pattern of someone who eats at a lot of different presentations.
Across 282 payments — averaging $21.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma Inc.$746
- Sun Pharmaceutical Industries Inc.$510
- AbbVie$501
- Regeneron Healthcare Solutions, Inc.$435
- Sanofi$426
- Galderma Laboratories, L.p.$351
- plus $3K from 32 others
Across 32 payments — averaging $9146.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sun Pharmaceutical Industries Inc.$271K
- Taro Pharmaceuticals USA, Inc.$22K
What the payments were for
- Food & beverage$5,88799%
- Education$401%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma Inc. | 41 | $746 |
| Sun Pharmaceutical Industries Inc. | 26 | $510 |
| AbbVie(2 entities) | 26 | $501 |
| Regeneron Healthcare Solutions, Inc. | 20 | $435 |
| Sanofi | 15 | $426 |
| Galderma Laboratories, L.p. | 23 | $351 |
| Mayne Pharma Commercial LLC | 13 | $288 |
| Novartis | 15 | $269 |
| Johnson & Johnson | 12 | $265 |
| UCB, Inc. | 5 | $175 |
| Boehringer Ingelheim | 6 | $166 |
| Arcutis Biotherapeutics, Inc. | 6 | $150 |
| Dermira, Inc. | 8 | $148 |
| Incyte Corporation | 7 | $143 |
| Pfizer | 8 | $141 |
| Journey Medical Corporation | 4 | $128 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $117 |
| Biofrontera Inc. | 5 | $108 |
| Mentor Worldwide LLC | 3 | $103 |
| Lilly USA, LLC | 4 | $99 |
| Apyx Medical Corporation | 1 | $88 |
| Dermavant Sciences, Inc. | 3 | $66 |
| Amgen | 3 | $60 |
| Verrica Pharmaceuticals Inc. | 2 | $48 |
| VYNE Pharmaceuticals Inc. | 2 | $48 |
| Kerecis Limited | 3 | $47 |
| Almirall LLC | 2 | $41 |
| Merz North America, Inc. | 1 | $40 |
| Encore Dermatology Inc. | 2 | $39 |
| Revance Therapeutics, Inc. | 1 | $28 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Organon | 1 | $24 |
| Bristol Myers Squibb | 1 | $23 |
| Stability Biologics, LLC | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Sandoz | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Glenmark Therapeutics Inc. | 1 | $14 |
How this compares
$5,927 in reported general payments places this provider in the 70th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 39 | $2,708 |
| Doxycycline Hyclate | 208 | $1,739 |
| Clobetasol Propionate | 22 | $1,113 |
| Betamethasone Dipropionate | 31 | $1,017 |
| Clindamycin Phosphate | 20 | $636 |
| Ketoconazole | 25 | $516 |
| Ciclopirox | 13 | $485 |
| SsdSilver Sulfadiazine | 54 | $460 |
| Triamcinolone Acetonide | 38 | $449 |
| Silver Sulfadiazine | 40 | $347 |
| CiclopiroxCiclopirox Olamine | 26 | $314 |
| Nystatin | 26 | $194 |
| Fluconazole | 20 | $193 |
| ValacyclovirValacyclovir Hcl | 11 | $163 |
| Mupirocin | 16 | $105 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Wesley Chapel
- Lisa Nyanda-ManaloWesley Chapel$110K
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.